Monte Rosa Therapeutics
Likely to Engage tag.Highly Engaged Employees

Manufacturing · Massachusetts, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

321 Harrison Ave Ste 900, Boston, Massac...

Phone Number

(617) 949-2643

Revenue

$28.7 Million

Stock Symbol

GLUE

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Monte Rosa Therapeutics

Founded in 2018 and based out of Boston, MA, Monte Rosa Therapeutics is a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the bodys natural mechanisms to selectively degrade therapeutically-relevant proteins.Explore more
Monte Rosa Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: GLUEShow more

Monte Rosa Therapeutics Org Chart

Markus Warmuth, Chief Executive Officer at Monte Rosa Therapeutics
United States flag for contact location.

Chief Executive Officer

PhoneEmail
Jennifer Champoux, Chief Operating Officer at Monte Rosa Therapeutics
United States flag for contact location.

Chief Operating Officer

PhoneEmail
Filip Janku, Chief Medical Officer at Monte Rosa Therapeutics
United States flag for contact location.

Chief Medical Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
DU
United States flag for contact location.

Vice President, Clinical Development

PhoneEmail
Kv
United States flag for contact location.

Vice President, Quality

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Monte Rosa Therapeutics

Compare insights from companies similar to Monte Rosa Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Monte Rosa Therapeutics

$28.7M
51-200
Public
$445.8M
2018
$71.6M
201-500
Public
$203M
2014
Troy Wilson, President, Chief Executive Officer & Chairman at Kura Oncology
Troy WilsonPresident, CEO & Chairman
$34.1M
51-200
Private
$290.7M
2013
Jean Bemis, Chief Operating Officer at Vividion Therapeutics
Jean BemisChief Operating Officer
$20.7M
51-200
Private
$209M
2020
Bell Zhong, Chief Financial Officer at Neomorph
Bell ZhongChief Financial Officer
$11.8M
51-200
Public
$170M
2017
Chris Storgard, Chief Medical Officer at Design Therapeutics
Chris StorgardChief Medical Officer
$7.8M
51-200
Private
$87M
2014
AC
Aviv CahanaProject Manager
<$5M
11-50
Private
$335M
2019
Illustration of an envelope

Monte Rosa Therapeutics Tech Stack

A closer look at the technologies used by Monte Rosa Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Monte Rosa Therapeutics

What is Monte Rosa Therapeutics's stock symbol?
Monte Rosa Therapeutics's stock symbol is GLUE
What is Monte Rosa Therapeutics's official website?
Monte Rosa Therapeutics's official website is www.monterosatx.com
What is Monte Rosa Therapeutics's Revenue?
Monte Rosa Therapeutics's revenue is $28.7 Million
What is Monte Rosa Therapeutics's SIC code?
Monte Rosa Therapeutics's SIC: 28,283
What is Monte Rosa Therapeutics's NAICS code?
Monte Rosa Therapeutics's NAICS: 32,325
How many employees does Monte Rosa Therapeutics have?
Monte Rosa Therapeutics has 51-200 employees
What industry does Monte Rosa Therapeutics belong to?
Monte Rosa Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Monte Rosa Therapeutics competition?
Monte Rosa Therapeutics top competitors include: Vividion Therapeutics, Neomorph, Design Therapeutics, Sonoma Biotherapeutics
What technology does Monte Rosa Therapeutics use?
Some of the popular technologies that Monte Rosa Therapeutics uses are: DocuSign, WordPress.org, iCIMS, PHP
How do I contact Monte Rosa Therapeutics?
Monte Rosa Therapeutics contact info: Phone number: (617) 949-2643 Website: www.monterosatx.com
What does Monte Rosa Therapeutics do?

Founded in 2018 and based out of Boston, MA, Monte Rosa Therapeutics is a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the bodys natural mechanisms to selectively degrade therapeutically-relevant proteins.... Read More

What are Monte Rosa Therapeutics social media links?
Monte Rosa Therapeutics Linkedin page Monte Rosa Therapeutics Twitter page
Who invested in Monte Rosa Therapeutics?
Monte Rosa Therapeutics has 15 investors including Cormorant Asset Management LP, New Enterprise Associates, Ridgeline and Versant Ventures.
Is Monte Rosa Therapeutics a public company?
Yes, Monte Rosa Therapeutics is a public company and is traded under the symbol GLUE
See more information about Monte Rosa Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.